Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
CHENNAI, INDIA: Orchid Chemicals & Pharmaceuticals Ltd is exiting its 50:50 manufacturing joint venture in China. The 50 per cent stake that Orchid holds in the Joint Venture company (NCPC-Orchid Pharmaceuticals) will be transferred to the partner company (NCPC) for a total cash consideration of $13.9 million.
“With the local Chinese players fast integrating, the operating conditions have grown quite competitive in China. Moreover, the products that the JV manufactures and markets in the local Chinese market have reached a mature stage resulting in flat growth prospects going forward. Hence, it was a prudent decision to relinquish our stake to the partner and exit the JV,” said K Raghavendra Rao, Chairman & Managing Director, Orchid Pharmaceuticals.
© WOC News
Login
MOSUL, IRAQ: The board of the Export-Import Bank of the United States (Ex-Im Bank) voted to guarantee a JPMorgan Chase loan totaling $35 million to De ...
HOUSTON, US: First Reserve Corporation and SK Capital Partners, have entered into a revised merger agreement with TPC Group Inc. As per the revised of ...
VISALIA, US: Edeniq, a biomaterials and sustainable fuels company, and Aemetis have entered into an agreement to install Edeniq technology at the Aeme ...
PASADENA, US: Kior Inc began production of cellulosic biofuels at its first commercial facility as other US biofuel companies struggle to shift their ...
SITTARD, THE NETHERLANDS: Stamicarbon, the licensing and IP centre of Maire Tecnimont SpA, has been awarded two contracts for licensing and process de ...
DES PLAINES, US: UOP LLC, a Honeywell company, has licensed to China’s Shandong Yangmei Hengtong Chemicals Co Ltd, its methanol-to-olefins (MTO) ...
Stay updated with the latest chemical industry trends and innovations.